Company / AR per Share
Xeris Biopharma Holdings, Inc. AR per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.34
FY2025
5-year range
$0.25 / $0.41
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
#76 of 113
Health Care
What the data says
At $0.34, Xeris Biopharma Holdings, Inc.'s ar per share ranks #76 of 113 in the Health Care sector. AR per Share has increased for 3 consecutive years, from $0.25 in FY2022 to $0.34 in FY2025.
Based on SEC 10-K filings.
0.34 in FY2025 with a 5-year CAGR of +16.2%.
Improved from $0.29 to $0.34 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
#76 of 113 in Health CareTop 67% of 113This company $0.34 Sector average $28.83
▼
-98.8% below sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 16.8% year-over-year.
- Ranks #76 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | +16.8% |
| FY2024 | $0.29 | +1.7% |
| FY2023 | $0.29 | +16.5% |
| FY2022 | $0.25 | -39.7% |
| FY2021 | $0.41 | +153.9% |
| FY2020 | $0.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026